Overview

Plasma Purification and Chronic Hepatitis B

Status:
Not yet recruiting
Trial end date:
2023-09-30
Target enrollment:
Participant gender:
Summary
To compare the efficacy of nucleoside analogues （HA） alone and plasma purification +HA in reducing HBV viral load.
Phase:
N/A
Details
Lead Sponsor:
Shanghai Pudong Hospital
Treatments:
Antiviral Agents